SEED Co.,Ltd. (TYO:7743)
Japan · Delayed Price · Currency is JPY 486.00
+4.00 (0.83%)
Aug 1, 2025, 3:30 PM JST
FARO Technologies Revenue
In the fiscal year ending March 31, 2025, SEED Co.,Ltd. had annual revenue of 33.23B JPY with 2.58% growth. SEED Co.,Ltd. had revenue of 8.04B in the quarter ending March 31, 2025, a decrease of -2.72%.
Revenue
33.23B
Revenue Growth
+2.58%
P/S Ratio
0.44
Revenue / Employee
33.74M
Employees
985
Market Cap
14.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 33.23B | 835.00M | 2.58% |
| Mar 31, 2024 | 32.40B | 1.80B | 5.89% |
| Mar 31, 2023 | 30.59B | 1.76B | 6.10% |
| Mar 31, 2022 | 28.84B | 218.00M | 0.76% |
| Mar 31, 2021 | 28.62B | -3.18B | -9.99% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.22B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 866.03B |
| Otsuka Holdings | 2,393.18B |
| Terumo | 1,036.17B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |